Dr Eileen Dunne
Senior Research Officer
Infection and Immunity
Murdoch Childrens Research Institute
Australia
Biography
Dr Eileen Dunne completed a PhD in microbiology from the Boston University School of Medicine in 2010. Her thesis research involved investigating the mechanisms of action of a synthetic antimicrobial peptide on Gram-positive bacteria. Prior to graduate school, she spent two years in Nicaragua as a member of the Peace Corps and worked at the Harvard School of Public Health. She joined the Pneumococcal Research group at Murdoch Childrens as a postdoctoral scientist in 2010, aiming to apply her background as a molecular microbiologist to research with a focus on international child health. Dr Dunne became a Senior Research Officer in 2012 and is currently involved in several international collaborations supporting the use of pneumococcal vaccines in resource-limited settings. She is a co-investigator on grants totalling over $11 million from funders including GAVI and the Bill and Melinda Gates Foundation.
Research Interest
Streptococcus pneumoniae and other respiratory pathogens in children.
Publications
-
Dunne EM, Tikkanen L, Balloch A, Gould K, Yoannes M, Phuanukoonnon S, Licciardi PV, Russell FM, Mulholland EK, Satzke C, Hinds J. Characterization of 19A-like 19F pneumococcal isolates from Papua new Guinea and Fiji. New microbes and new infections. 2015 Sep 30;7:86-8.
-
Boelsen LK, Dunne EM, Lamb KE, Bright K, Cheung YB, Tikoduadua L, Russell FM, Mulholland EK, Licciardi PV, Satzke C. Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes. Vaccine. 2015 Oct 13;33(42):5708-14.
-
Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK. The PneuCarriage project: a multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies. PLoS medicine. 2015 Nov 17;12(11):e1001903.
